• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Remdesivir—now called VEKLURY—

M

Mary Wilson

Well-known member
Allocation of Commercially Available Remdesivir by Jurisdiction

HHS’ Office of the Assistant Secretary for Preparedness and Response oversees the allocation and distribution of commercially available Remdesivir.

https://www.phe.gov/emergency/event...on-MCM/Pages/commercial-allocation-table.aspx

Remdesivir for the Commercial Marketplace

Hospitals will pay no more than the wholesale acquisition cost (WAC) set by Gilead, which amounts to approximately $3,200 per treatment course. A treatment course of remdesivir is, on average, 6.25 vials.

https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Pages/factsheet.aspx
 
You must log in or register to reply here.
Back
Top Bottom